The lead section of this article may need to be rewritten. (June 2017) (Learn how and when to remove this template message)
Ibrahim Abouleish (23 March 1937 – 15 June 2017) began his chemistry and medicine studies at the age of 19 in Austria. He did his doctorate in 1969 in the field of pharmacology and then worked in leading positions within pharmaceutical research. During this time he was granted patents for a number of new medicines, especially for osteoporosis and arteriosclerosis.
23 March 1937|
|Died||15 June 2017
In 2003, Ibrahim Abouleish and SEKEM received the Right Livelihood Award for integrating the commercial success with promotion of the social and cultural development of society. He was selected as an "Outstanding Social Entrepreneur" by the Schwab Foundation in 2004. In 2006 he was appointed as a councillor at the World Future Council. In 2012, Dr. Ibrahim Abouleish was appointed an Oslo Business for Peace Honouree, receiving his award at Oslo City Hall, from The Business for Peace Foundation. In 2013 he received the Global Thinkers Forum 2013 Award for Excellence in Positive Change.
- "وفاة الدكتور إبراهيم أبو العيش الحاصل على جائزة نوبل البديلة للتنمية". elyomnew.com (in Arabic). 2017-06-15. Retrieved 2017-06-16.
- CSR Europe
- World Future Council